ACETYLATOR PHENOTYPE AND THE CLINICAL PHARMACOLOGY OF SLOW-RELEASE PROCAINAMIDE
Open Access
- 1 December 1976
- journal article
- Published by Wiley
- Vol. 3 (6) , 1023-1026
- https://doi.org/10.1111/j.1365-2125.1976.tb00352.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Acetylation of procaine amide in man. A preliminary communicationEuropean Journal of Clinical Pharmacology, 1975
- ACETYLATION OF PROCAINE AMIDE IN MAN STUDIED WITH A NEW GAS CHROMATOGRAPHIC METHODBritish Journal of Clinical Pharmacology, 1974
- Use of plasma levels in evaluation of procainamide dosage.Heart, 1974
- Plasma levels of procaine amide after administration of conventional and sustained-release tabletsEuropean Journal of Clinical Pharmacology, 1973
- ACETYLATOR STATUS AND RESPONSE TO PHENELZINE IN DEPRESSED PATIENTSThe Lancet, 1973
- Simplified Method for Determining Acetylator PhenotypeBMJ, 1972
- PHARMACOKINETICS OF PROCAINAMIDE IN MAN*Annals of the New York Academy of Sciences, 1971
- Antiarrhythmic Prophylaxis with Procainamide in Acute Myocardial InfarctionNew England Journal of Medicine, 1969
- An improved and simplified method of detecting the acetylator phenotype.Journal of Medical Genetics, 1969
- PROPHYLACTIC PROCAINE AMIDE IN MYOCARDIAL INFARCTIONHeart, 1961